简体中文
繁體中文
English
Pусский
日本語
ภาษาไทย
Tiếng Việt
Bahasa Indonesia
Español
हिन्दी
Filippiiniläinen
Français
Deutsch
Português
Türkçe
한국어
العربية
Abstract:The worlds prominent derivatives marketplace, CME Group announced yesterday that the platform saw a sharp rise in activity across SOFR futures and SOFR options. On 10 February, SOFR futures surpassed 2 million contracts, the highest single-day trading volume on record.
SOFR futures crossed the level of 2 million contracts on 10 February.
The trading activity across SOFR options also increased.
10 February remained a landmark day for CME as volumes in SOFR options also touched a record high of 130,200 contracts. SOFR options open interest reached a record of 656,977 contracts. In terms of SOFR futures open interest, the number crossed 3.2 million contracts.
“Our SOFR futures and options have both grown exponentially since the start of the year, as clients are increasingly turning to our deep, liquid SOFR-based products to manage their risk,” said Agha Mirza, Global Head of Rates and OTC Products, CME Group. “In particular, SOFR options are growing at an unprecedented pace for a nascent options market, averaging more than 65,000 contracts per day during the month of February.”
The overall volumes related to SOFR futures grew consistently in 2021. CME started 2022 with strong growth in equity index ADV.
SOFR Futures ADV
The recent record volumes across SOFR futures and options were the result of a consistent rise in ADV throughout February.
“In February month-to-date, SOFR futures average daily volume (ADV) has grown to 946,794 contracts per day, compared to a record monthly ADV of 731,126 contracts per day in January. At the same time, SOFR futures ADV is now equivalent to more than 33% of all Eurodollar futures ADV. In addition, Eurodollar and SOFR futures and options ADV at CME Group have grown to more than 5.5 million contracts a day, with the majority of these futures contracts linked to each other through the ISDA spread,” CME added.
CME Group, which operates a major US derivatives exchange, reported $1.1 billion in revenue for Q4 of 2021.
Disclaimer:
The views in this article only represent the author's personal views, and do not constitute investment advice on this platform. This platform does not guarantee the accuracy, completeness and timeliness of the information in the article, and will not be liable for any loss caused by the use of or reliance on the information in the article.
2 Days Left!
3 Days Left!
4 Days Left
Seeing Diversity Trading Safely